1. AB0417 EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO DURATION OF PRIOR CSDMARD TREATMENT AND NUMBER OF PRIOR CSDMARDS: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 TRIALS. (June 2019) Authors: Aletaha, Daniel; Gomez-Reino, Juan Jose; Burmester, Gerd Rdiger; Vollenhoven, Ronald van; Luis Rivas, Jose; Benkhalifa, Salim; Dahl, Palle; Shi, Harry; Wang, Lisy Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0449 PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES. (June 2019) Authors: Taylor, Peter C.; Laar, Mart van de; Curtis, Jeffrey R.; Azevedo, Valderilio F.; Rivas, Jose Luis; Dahl, Palle; Wang, Lisy; Iikuni, Noriko; Shi, Harry; Woolcott, John; Benkhalifa, Salim; Gomez-Reino, Juan Jose; Dougados, Maxime Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0454 FREQUENCY AND DURATION OF EARLY NON-SERIOUS ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5 MG TWICE DAILY AS MONOTHERAPY AND COMBINATION THERAPY. (June 2019) Authors: Dikranian, Ara; Wollenhaupt, Jürgen; Azevedo, Valderilio F.; Bessette, Louis; Gold, David; Rivas, Jose Luis; Shi, Harry; Wang, Lisy; Woolcott, John; Shapiro, Andrea; Nash, Peter Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis1. Issue 11 (November 2014) Authors: Cohen, Stanley; Radominski, Sebastião C.; Gomez‐Reino, Juan J.; Wang, Lisy; Krishnaswami, Sriram; Wood, Susan P.; Soma, Koshika; Nduaka, Chudi I.; Kwok, Kenneth; Valdez, Hernan; Benda, Birgitta; Riese, Richard Journal: Arthritis & rheumatology Issue: Volume 66:Issue 11(2014) Page Start: 2924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies. (15th October 2020) Authors: van der Heijde, Désirée; Landewé, Robert B M; Wollenhaupt, Jürgen; Strengholt, Sander; Terry, Ketti; Kwok, Kenneth; Wang, Lisy; Cohen, Stanley Journal: Rheumatology Issue: Volume 60:Number 4(2021) Page Start: 1708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. Issue 2 (2nd June 2022) Authors: Navarro-Compán, Victoria; Wei, James Cheng-Chung; Van den Bosch, Filip; Magrey, Marina; Wang, Lisy; Fleishaker, Dona; Cappelleri, Joseph C; Wang, Cunshan; Wu, Joseph; Dina, Oluwaseyi; Fallon, Lara; Strand, Vibeke Journal: RMD open Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites. (17th April 2021) Authors: Wang, Ellen Q.; Le, Vu; O'Gorman, Melissa; Tripathy, Sakambari; Dowty, Martin E.; Wang, Lisy; Malhotra, Bimal K. Journal: Journal of clinical pharmacology Issue: Volume 61:Number 10(2021) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites. (15th February 2022) Authors: Wang, Ellen Q.; Le, Vu; Winton, Jennifer A.; Tripathy, Sakambari; Raje, Sangeeta; Wang, Lisy; Dowty, Martin E.; Malhotra, Bimal K. Journal: Journal of clinical pharmacology Issue: Volume 62:Number 4(2022) Page Start: 505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data. (22nd March 2019) Authors: Lee, Eun Bong; Yamanaka, Hisashi; Liu, Yi; Tsai, Wen‐Chan; Chen, Connie; Kwok, Kenneth; Yoo, Hyun–Jeong; Llamado, Lyndon J.; Wang, Lisy; Luo, Yingchun; Sugiyama, Naonobu; Tanaka, Yoshiya Journal: International journal of rheumatic diseases Issue: Volume 22:Number 6(2019) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis. Issue 5 (2nd April 2019) Authors: van Vollenhoven, Ronald; Lee, Eun Bong; Strengholt, Sander; Mojcik, Christopher; Valdez, Hernan; Krishnaswami, Sriram; Biswas, Pinaki; Lazariciu, Irina; Hazra, Anasuya; Clark, James D.; Hodge, Jennifer; Wang, Lisy; Choy, Ernest Journal: Arthritis & rheumatology Issue: Volume 71:Issue 5(2019) Page Start: 685 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗